Log in to save to my catalogue

The fate of eyes with wet AMD beyond four years of anti-VEGF therapy

The fate of eyes with wet AMD beyond four years of anti-VEGF therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1994359284

The fate of eyes with wet AMD beyond four years of anti-VEGF therapy

About this item

Full title

The fate of eyes with wet AMD beyond four years of anti-VEGF therapy

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Graefe's archive for clinical and experimental ophthalmology, 2018-04, Vol.256 (4), p.823-831

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Real-life studies on long-term functional outcome of anti-VEGF treatment for wet age-related macular degeneration (wAMD) are limited. We therefore assessed the 10-year outcomes in our patients.
Methods
In this retrospective study, all patients with newly diagnosed wAMD that had received minimally three intravitreal injections betwe...

Alternative Titles

Full title

The fate of eyes with wet AMD beyond four years of anti-VEGF therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1994359284

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1994359284

Other Identifiers

ISSN

0721-832X

E-ISSN

1435-702X

DOI

10.1007/s00417-018-3907-y

How to access this item